ONE MEDICATIONS, AND YOU MAY HAVE HEARD THE SNIFFLES AND COUGHS WERE OFFICIALLY AND RESPIRATORY VIRUS SEASON. AND THAT’S WHY IT IS SUCH A CRITICAL TIME OF YEAR TO TAKE CARE OF YOURSELF AND ALSO TAKE ...

The flu has started spreading earlier than usual in some parts of the country, prompting concerns that cases could soon erupt as millions of Americans travel and gather for Thanksgiving and other ...

The subclade K flu strain is a variant of the H3N2 virus. A new influenza strain this flu season is raising concerns as Americans hit the roads and take to the skies ahead of the Thanksgiving holiday, ...

Influenza is picking up in the U.S., and public health experts are bracing for signs of another brutal season with the virus. Last year one of the worst waves of flu in recent decades took the U.S. by ...

A new strain of the flu called subclade K could make for a particularly nasty flu season across the country, according to public health experts. The strain already caused Japan to declare an influenza ...

NEW YORK (AP) — The U.S. flu season is starting slowly, and it’s unclear if it will be as bad as last winter’s, but some health experts are worried as U.S. Centers for Disease Control and Prevention ...

The U.S. flu season is starting slowly, and it’s not clear if it will be as bad as last winter’s NEW YORK -- The U.S. flu season is starting slowly, and it's unclear if it will be as bad as last ...

Influenza season may start to pick up soon in the Lehigh Valley. Flu cases are rising in eastern Pennsylvania, and both St. Luke’s University Health Network and Lehigh Valley Health Network are seeing ...

In a large-scale trial, modRNA was significantly better at preventing confirmed flu cases than a typical seasonal flu shot. Reading time 3 minutes Next-generation vaccines could make the flu season ...

This year’s flu season is already raising alarms among public health officials and infectious disease experts. According to the BBC, the U.K.’s National Health Service (NHS) has issued an "SOS" ...

Pfizer has released the full data from its phase 3 trial of an mRNA flu vaccine candidate, with the potential new shot demonstrating 34.5% greater efficacy compared to a control vaccine. Of 9,225 ...